Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 224,884,422 papers from all fields of science
Search
Sign In
Create Free Account
esterbut-3
Known as:
3n-But
, monoacetone glucose 3-butyrate
, 3-O-butanoyl-1,2-O-isopropylidene-alpha-D-glucofuranose
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
Broader (2)
Butyrates
Glucose
analogs & derivatives
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
BcI-2 Expression Regulates Sodium Butyrate-induced Apoptosis in Human MCF-7 Breast Cancer Cells 1
Mahitosh
,
Mandal
,
Rakesh
,
Kumar
2005
Corpus ID: 53551669
Sodium butyrate (butyrate) is a potent growth inhibitor and differentiating agent for many cell types, including breast cancer…
Expand
1994
1994
Selection of a highly tumorigenic breast cancer cell line sensitive to estradiol to evidence in vivo the tumor-inhibitory effect of butyrate derivative Monobut-3.
P. Planchon
,
V. Magnien
,
A. Starzec
,
G. Prévost
Life Science
1994
Corpus ID: 25023558
1992
1992
Differential effects of butyrate derivatives on human breast cancer cells grown as organotypic nodules in vitro and as xenografts in vivo.
P. Planchon
,
V. Magnien
,
+4 authors
D. Brouty‐boye
In Vivo
1992
Corpus ID: 38117305
The antiproliferative and cytodifferentiating effects of a new stable butyric derivative, monobut-3, were compared using human…
Expand
1992
1992
Morphology and intermediate filament composition of human mammary epithelial cells treated with stable butyrate derivative.
P. Planchon
,
V. Magnien
,
G. Ronco
,
P. Villa
,
D. Brouty‐boye
Anticancer Research
1992
Corpus ID: 19232171
A new stable butyrate derivative monobut-3 was previously shown to inhibit proliferation and promote differentiation in human…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE
or Only Accept Required